Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04154189
Title A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eisai Inc.
Indications

osteosarcoma

Therapies

Etoposide + Ifosfamide

Etoposide + Ifosfamide + Lenvatinib

Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | CAN | BEL | AUT


No variant requirements are available.